[Federal Register Volume 65, Number 51 (Wednesday, March 15, 2000)]
[Notices]
[Page 13983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-6421]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

[HCFA-3032-N]


Medicare Program; Meeting of the Medical and Surgical Procedures 
Panel of the Medicare Coverage Advisory Committee--April 12 and 13, 
2000

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Medical and 
Surgical Procedures Panel of the Medicare Coverage Advisory Committee 
(MCAC). The panel provides advice and recommendations to the agency 
about clinical coverage issues. The panel will hear and discuss 
presentations from interested persons regarding the treatment of non-
neurogenic urinary incontinence in adults. The meeting will focus on 
two treatment options: biofeedback and pelvic floor electrical 
stimulation. Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

DATES: The Meeting: The meeting will be held on April 12, 2000 from 
8:00 a.m. until 5:15 p.m. and on April 13, 2000, from 8:00 a.m. until 
3:00 p.m. E.S.T.
    Deadline for Presentations and Comments: March 22, 2000, 5 p.m.
    Special Accommodations: Persons attending the meeting who are 
hearing impaired and require sign language interpretation, or have a 
condition that requires other special assistance or accommodations, are 
asked to notify the Executive Secretary by March 31, 2000.



ADDRESSES:
    The Meeting: The meeting will be held at The Baltimore Convention 
Center, One West Pratt Street, Baltimore, MD 21201.
    Presentations and Comments: Submit formal presentations and written 
comments to Constance A. Conrad, Executive Secretary; Office of 
Clinical Standards and Quality; Health Care Financing Administration; 
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
    Website: You may access up-to-date information on this meeting at 
www.hcfa.gov/quality/8b.htm.
    Hotline: You may access up-to-date information on this meeting on 
the HCFA Advisory Committee Information Hotline, 1-877-449-5699 (toll 
free) or in the Baltimore area (410) 786-9379.

FOR FURTHER INFORMATION CONTACT: Constance A. Conrad, Executive 
Secretary, 410-786-4631.

SUPPLEMENTARY INFORMATION: On August 13, 1999, we published a notice 
(64 FR 44231) to describe the MCAC, which provides advice and 
recommendations to us about clinical issues. This notice announces the 
following public meeting of the MCAC:
    Current Panel Members:
    Alan M. Garber, M.D.; Michael D. Maves, M.D.; Angus M. McBryde, 
M.D.; H. Logan Holtgrewe, M.D.; Kenneth P. Brin, M.D.; Les J. Zendle, 
M.D.; Bruce Sigsbee, M.D.; Linda D. Bradley, M.D.; James P. Rathmell, 
M.D.; Arnold M. Epstein, M.D.; Phyllis E. Greenberger, M.S.W.; Marshall 
S. Stanton, M.D.
    Meeting Topic:
    The Panel will hear and discuss presentations from interested 
persons regarding the treatment of non-neurogenic urinary incontinence 
in adults. The meeting will focus on two treatment options: biofeedback 
the first day and pelvic floor electrical stimulation the second day.
    Procedure and Agenda:
    This meeting is open to the public. The panel will hear oral 
presentations from the public for approximately 2 hours and 30 minutes 
on each day of the meeting. The Panel may limit the number and duration 
of oral presentations to the time available. If you wish to make formal 
presentations you must notify the For Further Information Contact 
person, and submit the following by the Deadline for Presentations and 
Comments date listed in the DATES section of this notice: a brief 
statement of the general nature of the evidence or arguments you wish 
to present, the names and addresses of proposed participants, and an 
estimate of the time required to make the presentation. We will request 
that you declare at the meeting whether or not you have any financial 
involvement with manufacturers of any items or services being discussed 
(or with their competitors).
    After the public presentation, we will make a presentation to the 
Panel. After our presentation, the Panel will deliberate openly on the 
topic. Interested persons may observe the deliberations, but the Panel 
will not hear further comments during this time except at the request 
of the chairperson. At the end of the Panel deliberations each day, the 
Panel will allow approximately a 30-minute open public session for any 
attendee to address issues specific to the topic. After which, the 
members will vote and the Panel will make its recommendation.


    Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)

    Dated: February 29, 2000.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 00-6421 Filed 3-14-00; 8:45 am]
BILLING CODE 4120-01-P